Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1)
Conditions:   Arthritis;   Arthralgia Intervention:   Drug: Methotrexate Sponsor:   AHS Cancer Control Alberta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma
Condition:   Non-hodgkin Lymphoma Interventions:   Drug: Methotrexate;   Drug: Rituximab (where available);   Drug: Ibrutinib Sponsors:   Canadian Cancer Trials Group;   Janssen Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1)
Conditions:   Arthritis;   Arthralgia Intervention:   Drug: Methotrexate Sponsor:   AHS Cancer Control Alberta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of add-on Dapsone Versus add-on Methotrexate in Patients With Bullous Pemphigoid
Condition:   Bullous Pemphigoid Interventions:   Drug: Prednisolone;   Drug: Dapsone;   Drug: Methotrexate Sponsor:   All India Institute of Medical Sciences, Bhubaneswar Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2023 Category: Research Source Type: clinical trials